CM Life Sciences, Inc. CMLF
11.60 0.00 (+0.00%)
At closeJul 23, 2021, 12:00 AM EDT
11.40 Day range 12.43
9.66 52-week range 27.18
- EPS (ttm)
- -0.009
- Shares out
- 44.27M
- P/E ratio
- -1288.89
- Volume
- 489.11K
- Avg volume
- 723.14K
- Open
- 12.30
- Previous close
- 11.60
- Day's range
- 11.40 – 12.43
- 52-week range
- 9.66 – 27.18
No chart data for this range yet.
Key statistics
- Enterprise value
- 641.82M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 128.89
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 167.96K
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 5.23%
- 50-day average
- 12.71
- 200-day average
- 14.38
Next earnings
Consensus EPS estimate 0.00.
About CM Life Sciences, Inc.
CM Life Sciences, Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company focuses on targeting life science companies. CM Life Sciences, Inc. was incorporated in 2020 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- i.cmlifesciencesspac.com
News
CM Life Sciences and Sema4 Announce Release of Definitive Proxy Statement for July 21 Shareholder Meeting to Vote on Business Combination 
3 Stocks Cathie Wood Keeps Buying 
Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement 
Cathie Wood's ARK Invest Buys Over 330,000 Shares of CM Life Sciences 
Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger 
CM Life Sciences Announces Filing of Amended Annual Report on Form 10-K Relating to Restatement of Financial Statements in Accordance with Recent SEC Guidance 
CM Life Sciences II: SomaLogic Is Great, But Post-Merger SPAC Dilution Should Frighten Investors 
CM Life Sciences: SPAC Acquires Sema4, A Promising AI Health Intelligence Co. 
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CM Life Sciences, Inc. - CMLF 
CMLF Stock Price Increases Over 80% Over The Past Week: Why It Happened
Your note
Sign in to keep a note on CMLF — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK Investment Management, LLC | 9.56% | 4,231,546 | 63.01M | Mar 30, 2021 |
| SB Management Ltd | 7.63% | 3,379,704 | 50.32M | Mar 30, 2021 |
| Weiss Multi-Strategy Advisers, LLC | 5.87% | 2,597,776 | 38.68M | Mar 30, 2021 |
| Alkeon Capital Management LLC | 5.22% | 2,310,000 | 34.40M | Mar 30, 2021 |
| Marshall Wace LLP | 4.60% | 2,038,507 | 30.35M | Mar 30, 2021 |
| Sachem Head Capital Management, LP | 3.39% | 1,500,000 | 22.34M | Mar 30, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ARK ETF Tr-ARK Genomic Revolution ETF | 10.30% | 4,560,227 | 63.89M | Jun 29, 2021 |
| ACAP Strategic Fund | 2.41% | 1,067,890 | 15.90M | Mar 30, 2021 |
| Weiss Strategic Interval Fd | 1.19% | 527,448 | 7.85M | Mar 30, 2021 |
| Brinker Capital Destinations Tr-Destinations Multi Strategy Alt Fd | 1.15% | 510,787 | 10.22M | Feb 27, 2021 |
| Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I | 0.78% | 344,284 | 6.89M | Feb 27, 2021 |
| Advantage Advisers Xanthus Fund, LLC | 0.76% | 335,323 | 4.99M | Mar 30, 2021 |